Evidence map›Paper›PMID 40789923›Full record

ArticleNature nanotechnology2025

Annexin A1 mRNA-loaded liposomes alleviate acute pancreatitis by suppressing STING pathway and promoting efferocytosis in macrophages.

Haizong Fang, Peidong You, Shengzhe Lin, Yuwei Wu, Jiajing Lin, Zelin Hou, Feihong Liang, Changgan Chen, Zhiyuan Wang, Linlin Chen and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature nanotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Haizong Fang *Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Peidong You *Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Shengzhe Lin *Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.ORCID http://orcid.org/0009-0000-2520-8957
Yuwei Wu *Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Jiajing Lin *Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Zelin Hou *Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Feihong LiangDepartment of General Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Changgan ChenDepartment of General Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.ORCID http://orcid.org/0000-0003-2296-8621
Zhiyuan WangDepartment of General Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Linlin ChenDepartment of Pathology, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Shihan ZhangDepartment of Pathology, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Xiaolan ChenThe Cancer Center, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Kui ZhaoSchool of Nursing, Yunnan University of Chinese Medicine, Kunming, People's Republic of China.ORCID http://orcid.org/0000-0001-9077-6838
Fengchun LuDepartment of General Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Minggui PanStanford University School of Medicine, Palo Alto, CA, USA.ORCID http://orcid.org/0000-0002-8368-6524
Yundong ZhouThe Second Department of Oncology, Huizhou First Hospital, Huizhou, People's Republic of China.
Chengliang YinFaculty of Medicine, Macau University of Science and Technology, Macau, People's Republic of China. chengliangyin@163.com.ORCID http://orcid.org/0000-0001-8262-5749
João CondeComprehensive Health Research Centre (CHRC), NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade NOVA de Lisboa, Lisbon, Portugal. joao.conde@nms.unl.pt.ORCID http://orcid.org/0000-0001-8422-6792
Heguang HuangDepartment of General Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China. heguanghuang22@163.com.ORCID http://orcid.org/0000-0003-2716-5975
Yu PanDepartment of General Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China. yupan199002@163.com.ORCID http://orcid.org/0000-0002-7417-4551

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) ERC-StG-2019-848325National Natural Science Foundation of China (National Science Foundation of China) 82103310
6 · The paper itself

Abstract

Acute pancreatitis (AP) is associated with high mortality rates and is characterized by increased cell death of acinar cells, with the premature release and activation of digestive enzymes. In its acute phase, AP is accompanied by increased efferocytosis, to clear phagocytic apoptotic cells; annexin A1 (Anxa1) is key to efferocytosis, but its role in AP is still unknown. Here we show that Anxa1 deficiency abrogates the efferocytosis of pancreatic macrophages, resulting in the accumulation of apoptotic acinar cells and necrosis. Moreover, we showed that nano-liposomes loaded with Anxa1 mRNA alleviate AP pathology by suppressing the cGAMP-cGAS-STING pathway and restoring efferocytosis in macrophages. Our results reveal the crucial function of Anxa1 in the efferocytosis of macrophages during AP and illustrate a novel nanotechnology treatment approach for AP that may be of potential therapeutic value in humans.

Indexed as

Annexin A1LiposomesMacrophagesMembrane ProteinsPancreatitisPhagocytosisRNA, MessengerAcinar CellsAnimalsApoptosisEfferocytosisHumansMaleMiceMice, Inbred C57BLSignal TransductionAnnexin A1annexin A1, mouseLiposomesMembrane ProteinsRNA, MessengerSting1 protein, mouseSTING Protein

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.